Long‐term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users
VERHOEF, T. I., REDEKOP, W. K., BUIKEMA, M. M., SCHALEKAMP, T., VAN DER MEER, F. J. M., LE CESSIE, S, WESSELS, J. A. M., VAN SCHIE, R. M. F., DE BOER, A., TEICHERT, M., VISSER, L. E., MAITLAND‐VAN DER ZEE, A. H.
Published in Journal of thrombosis and haemostasis (01.04.2012)
Published in Journal of thrombosis and haemostasis (01.04.2012)
Get full text
Journal Article
Evaluation of the effects of single‐nucleotide polymorphisms in CYP3A4 and CYP4F2 on stable phenprocoumon and acenocoumarol maintenance doses
Schie, R. M. F., Aoussar, A., Meer, F. J. M., Boer, A., Maitland‐van der Zee, A. H.
Published in Journal of thrombosis and haemostasis (01.06.2013)
Published in Journal of thrombosis and haemostasis (01.06.2013)
Get full text
Journal Article
An evaluation of gene–gene interaction between the CYP2C9 and VKORC1 genotypes affecting the anticoagulant effect of phenprocoumon and acenocoumarol
VAN SCHIE, R. M. F., BABAJEFF, A. M. V., SCHALEKAMP, T., WESSELS, J. A. M., LE CESSIE, S., de BOER, A., VAN DER MEER, F. J. M., VAN MEEGEN, E., VERHOEF, T. I., ROSENDAAL, F. R., MAITLAND‐VAN DER ZEE, A. H.
Published in Journal of thrombosis and haemostasis (01.05.2012)
Published in Journal of thrombosis and haemostasis (01.05.2012)
Get full text
Journal Article